On the recordSeptember 10, 2019
Unfortunately, there is little or no transparency in how the prior authorizations are judged, nor the guidelines by which the reviewers look at the clinical information provided.
Source
congress.govEditor's note · Context
Rogers criticizes the lack of transparency in prior authorization processes.
Share & report
More from Hal Rogers
Jul 23, 2020
Mr. Speaker, I rise in opposition to the gentleman's amendment. This bill funds a number of important programs that are part of our national security. While I believe there is room for a small reduction, taking cuts across the board is not…
Jul 28, 2021
Madam Speaker, I urge a ``yes'' vote on this amendment, and I yield back the balance of my time. {time} 1515
Feb 9, 2022
My words were not acceptable. And I expressed my regret to her first and foremost.
Other voices in this conversation
